patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
resmetirom
Marketedupdated 2mo agoby $MDGL MADRIGAL PHARMACEUTICALS, INC.
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for non-alcoholic fatty liver disease and cirrhosis of liver and 5 investigational indications.
all catalysts(4)
approval · 4
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that